基于CRISPR的治疗基因组编辑用于遗传性血液疾病
Sébastien Levesque1,2,3,4,5, Daniel E Bauer6,7,8,9,10
1Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Nature reviews. Drug discovery
|July 14, 2025
概括
克里斯普尔基因组编辑通过纠正造血干细胞 (HSC) 中的突变,为血液疾病提供了新的治疗方法. 在下一代基因疗法的交付和向HSC方面仍然存在挑战.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
背景情况:
- 基于CRISPR的技术为纠正致病突变提供了多功能工具.
- 治疗性基因组编辑特别适应血液和免疫系统疾病.
- 目前的ex vivo基因编辑需要复杂的细胞操纵和毒性调节.
研究的目的:
- 对遗传性血液学疾病的最新基因组编辑技术进行审查.
- 突出突出进展并讨论针对造血干细胞 (HSC) 的挑战.
- 为了探索下一代基因疗法的核酶,基编辑器和主要编辑器.
主要方法:
- 审查当前的基因组编辑技术,包括CRISPR-Cas9,基编辑器和主要编辑器.
- 对血造干细胞 (HSC) 修饰的ex vivo和in vivo方法的分析.
- 讨论治疗遗传性血液疾病的临床应用和挑战.
主要成果:
- 首个FDA批准的CRISPR-Cas9疗法 (exa-cel/Casgevy) 证明了治疗状细胞疾病和β-thalassaemia的潜力.
- 基因组编辑技术显示出解决遗传性血液学疾病中未满足的临床需求的前景.
- 对于广泛的治疗应用,有效的输送和静止HSC的向仍然是重大挑战.
结论:
- 基因组编辑技术,包括CRISPR,基编辑器和主要编辑器,在治疗遗传性血液疾病方面具有重大前景.
- 克服体外和体内造血干细胞 (HSC) 向的挑战对于推进基因疗法至关重要.
- 持续的研究和技术开发对于实现治疗基因组编辑的全部潜力至关重要.
相关概念视频
CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
CRISPR/Cas9 Genome Editing
272
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
272
What is Genetic Engineering?
75.6K
Overview
75.6K
Homologous Recombination
52.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.4K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K


